ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,106.48
-0.99%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) News

AXGN

Axogen (AXGN)

Axogen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AXGN
DateTimeSourceHeadlineSymbolCompany
16/04/202421:00GlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
09/03/202409:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
09/03/202409:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
09/03/202408:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
08/03/202410:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
08/03/202408:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
07/03/202400:59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
07/03/202400:53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AXGNAxogen Inc
07/03/202400:45Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AXGNAxogen Inc
06/03/202408:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
06/03/202408:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
05/03/202423:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
05/03/202423:00GlobeNewswire Inc.Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsNASDAQ:AXGNAxogen Inc
24/02/202408:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
24/02/202408:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
24/02/202408:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
15/02/202407:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
14/02/202408:30GlobeNewswire Inc.Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024NASDAQ:AXGNAxogen Inc
13/02/202405:21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXGNAxogen Inc
07/02/202409:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
03/02/202408:15GlobeNewswire Inc.Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
03/02/202401:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
27/01/202403:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
19/01/202409:00GlobeNewswire Inc.Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve CapNASDAQ:AXGNAxogen Inc
12/01/202409:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
12/01/202409:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
12/01/202409:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
08/01/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
06/01/202409:21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AXGNAxogen Inc
05/01/202409:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
 Showing the most relevant articles for your search:NASDAQ:AXGN

Your Recent History

CCOM
SILVER
SILVER
ASX
CSL
CSL
ASX
TLS
Telstra
ASX
WES
Wesfarmers
ASX
WDC
Westfield
ASX
XAO
Australian SE All Ordina...
ASX
MQG
Macquarie
FX
AUDUSD
AUD vs US Dollar
NASDAQ
NVDA
NVIDIA
ASX
WOW
Woolworths
ASX
BHP
BHP
NYSE
NKE
Nike
ASX
WPL
Woodside Petroleum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved